Lundin Law PC announces it is investigating claims against AngioDynamics Inc. (“AngioDynamics” or the “Company”) (Nasdaq: ANGO) concerning possible violations of federal securities laws. The investigation is related to allegations that certain statements issued by AngioDynamics were false and misleading concerning the Company’s financial performance.
To join this class action lawsuit, please contact Brian Lundin, Esquire, of Lundin Law PC, at 888-713-1033, or via email at brian@lundinlawpc.com.
The investigation will focus on the Company’s first quarter earnings release. AngioDynamic attributed its poor financial performance to the withdrawal of its Morpheus PICC line and “currency head-winds.”
No class has been certified in the above action. Until a class is certified, you are not considered represented by an attorney. You may also choose to do nothing and be an absent class member.
Lundin Law PC was created by Brian Lundin, a securities litigator based in Los Angeles.
This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and ethical rules.
View source version on businesswire.com: http://www.businesswire.com/news/home/20151106006008/en/
Contacts:
Brian Lundin, Esq.
Telephone: 888-713-1033
Facsimile:
888-713-1125
brian@lundinlaw.com
LundinLawPC.com
